- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07569549
Surgery for Thumb Base Osteoarthritis: Joint Replacement vs. Trapeziectomy (BASTION)
BASTION - BASe of Thumb Osteoarthritis Management Non-inferiority Trial: Surgical Treatment of First Carpometacarpal Joint Osteoarthritis: A Comparison Between Joint Replacement and Trapeziectomy
The goal of this clinical trial is to learn if the surgical method with total joint arthroplasty, (TOUCH joint prosthesis), is as good as or better than the traditional surgical method, trapezectomy, to treat thumb base joint osteoarthritis.
The main questions it aims to answer are:
Does surgery with total joint arthroplasty provide better power grip and pinch grip strength compared to traditional surgery?
What is the long-term risk of complications for both methods?
Which method is more cost-effective for the healthcare system?
Researchers will compare total joint arthroplasty (TOUCH) to trapezectomy (a procedure where a bone in the thumb base is removed) to see which method provides the best results for the patient.
Participants will:
Be randomized to undergo either an operation with total joint arthroplasty or a trapezectomy.
Undergo an initial evaluation and a health economic cost analysis after one year.
Attend follow-up checkups at 2, 5, and 10 years post-surgery to evaluate long-term function and the durability of the prosthesis.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Background and Rationale:
Basal joint arthritis of the thumb (trapeziometacarpal osteoarthritis) is a common condition causing pain and reduced hand function. While trapeziectomy with ligament reconstruction/capsuloplasty has long been a gold standard, total joint arthroplasty, such as the TOUCH prosthesis, has gained popularity. However, there is a lack of high-quality prospective randomized controlled trials (RCTs) comparing these methods regarding long-term functional outcomes, complication rates, and cost-effectiveness. This study aims to compare the clinical and health-economic outcomes of total joint arthroplasty with TOUCH prosthesis versus trapeziectomy with capsuloplasty.
Study Design and Randomization:
This is a prospective, randomized controlled trial. Following informed consent obtained by the attending surgeon, participants are randomized to either:
- Total joint arthroplasty using the TOUCH prosthesis.
- Trapeziectomy with capsuloplasty. Randomization is performed in close proximity to the day of surgery. Due to the nature of the interventions, participants are informed of the surgical method postoperatively.
Procedures and Follow-up
- Surgical Intervention: Both procedures are performed according to standardized institutional protocols.
- Postoperative Care (Trapeziectomy): The thumb is immobilized in a cast for 3 weeks, followed by a standardized rehabilitation program led by occupational and physical therapists.
- Postoperative Care (total joint arthroplasty): A stable soft dressing is applied for 3 weeks, followed by the same rehabilitation protocol.
- Follow-up Schedule: Participants are evaluated at 3 weeks, 6 weeks, 12 weeks, 12 months, 24 months, 5 years, and 10 years postoperatively.
- Imaging: Radiographic evaluations are performed for the prosthesis group at 6 weeks, 12 months, 24 months, 5 years, and 10 years to monitor for prosthesis loosening or "z-deformity" (MCP joint hyperextension) compared to the trapeziectomy group.
Data Management and Quality Assurance:
Data is collected and managed using REDCap (Research Electronic Data Capture) to ensure data integrity and validation. Physical informed consent forms are stored securely at the Department of Hand Surgery. Source data verification is performed by comparing registry data against electronic medical records and paper-based Case Report Forms (CRFs).
Sample Size and Power Calculation:
The primary outcome is Jamar grip strength at 12 months. Based on a Minimal Clinically Important Difference (MCID) of 6.5 kg and a standard deviation (SD) of 8.5 kg (derived from existing literature and pilot data), a power calculation (90% power, alpha 0.05, two-sided t-test) determined a requirement of 37 patients per group. To account for a 10% dropout rate, the total cohort size is set at 84 patients (42 per arm).
Health Economic Analysis:
A comprehensive health economic evaluation will be conducted to compare the total costs of both methods. This analysis includes:
- Direct Costs: Implant costs, anesthesia, surgical time, and healthcare utilization (number of visits).
- Indirect Costs: Duration of sick leave and time to return to work.
- Secondary Metrics: Analgesic consumption (paracetamol and opioids), patient-reported quality of life (EQ-5D), and "pain-free days" based on NRS (Numerical Rating Scale) assessments.
The objective is to determine if the higher initial cost of the TOUCH prosthesis is offset by faster recovery, reduced sick leave, and improved long-term productivity.
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Eva Nordin, Clinical research nurse
- Telefonnummer: +46(0) 186119630
- E-post: eva.nordin@akademiska.se
Studera Kontakt Backup
- Namn: Elias Gardell, MD, attending hand surgeon
- Telefonnummer: +46 (0) 186171544
- E-post: elias.gardell@uu.se
Studieorter
-
-
-
Uppsala, Sverige
- Rekrytering
- Department of Handsurgery, Uppsala University Hospital
-
Kontakt:
- Elias Gardell, MD, attending hand surgeon
- Telefonnummer: +46(0) 186171544
- E-post: elias.gardell@uu.se
-
Kontakt:
- Sara Edsfeldt, MD, PhD, senior attending
- Telefonnummer: +46 (0) 186119031
- E-post: sara.edsfeldt@uu.se
-
Huvudutredare:
- Sara Edsfeldt, MD, PhD, senior attending
-
Örebro, Sverige
- Har inte rekryterat ännu
- Örebro University Hospital
-
Kontakt:
- Eva Lundqvist, MD, PhD, senior attending
- Telefonnummer: +46(0) 196025175
- E-post: eva.lundqvist@regionorebrolan.se
-
Huvudutredare:
- Eva Lundqvist, MD, PhD, senior attending
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Beskrivning
Inclusion Criteria:
- Age 40-80 years at inclusion
- CMC-joint osteoarthritis grade 1-3 (Eaton-Littler classification)
- Rest pain or pain reducing hand function with indication for surgery
- Insufficient relief from non-operative treatment for ≥3 months (orthosis, OTC analgesics, cortisone injection)
- Eligible for both prosthesis and trapezectomy per including surgeon
- Non-smoker or complete smoking cessation ≥6 weeks prior to surgery
Exclusion Criteria:
- Previous surgery to thumb base or STT-joint
- Ongoing chronic pain condition
- Dementia or cognitive impairment
- Trapezium height <7 mm on plain radiograph
- Active smoker
- Osteoarthritis grade 4 (Eaton-Littler)
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Arm 1 -Dual Mobility Prosthesis (TOUCH)
TOUCH Total Joint Arthroplasty (n=42).
Implantation of TOUCH trapeziometacarpal prosthesis (Kerimedical).
Soft bandage for 3 weeks postoperatively, followed by rehabilitation per national guidelines.
|
Surgical implantation of the TOUCH trapeziometacarpal total joint prosthesis (Kerimedical).
The prosthesis consists of an uncemented stainless steel stem inserted into the first metacarpal and a dual cup mobility system with a polyethylene ball articulating against a metal cup fixed in the trapezium.
The stem is available in straight or 15-degree angled neck configurations.
Postoperative management consists of a stable soft dressing for 3 weeks to allow early controlled mobilization, followed by a standardized hand therapy rehabilitation protocol.
Andra namn:
|
|
Aktiv komparator: Arm 2 - Trapeziectomy and Capsular Reconstruction
Trapezectomy with capsuloplasty (n=42).
Excision of trapezium with dorsal capsule flap capsuloplasty.
Cast immobilization for 3 weeks postoperatively, followed by rehabilitation per national guidelines.
|
Surgical excision of the trapezium bone (trapeziectomy) followed by capsuloplasty using a distally based dorsal capsular flap, without tendon interposition.
The capsular flap is sutured to stabilize the base of the first metacarpal.
No implant or tendon graft is used.
Postoperatively, a cast immobilizing the thumb in functional position is applied for 3 weeks, followed by a standardized hand therapy rehabilitation protocol.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Hand grip strength
Tidsram: Measured at 12 months postoperatively
|
Hand grip strength (JAMAR dynamometer) at 12 months post operatively
|
Measured at 12 months postoperatively
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Key-pinch grip strength
Tidsram: Measured at 6 weeks, 12 weeks, and 12 months postoperatively
|
Key-pinch strength measured by pinch-gauge in kilograms
|
Measured at 6 weeks, 12 weeks, and 12 months postoperatively
|
|
Pinch grip strength
Tidsram: Measured at 6 weeks, 12 weeks and 12 months postoperatively
|
3-finger pinch strength measured by pinch gauge in kilograms
|
Measured at 6 weeks, 12 weeks and 12 months postoperatively
|
|
Postoperative Pain Intensity on a Numeric Rating Scale (NRS)
Tidsram: Measured at 6 weeks, 12 weeks and 12 months postoperatively
|
Pain measured with the Numerical Rating Scale (NRS) at rest and load, where 0 is "no pain" and 10 is "worst imaginable pain"
|
Measured at 6 weeks, 12 weeks and 12 months postoperatively
|
|
Range of movement
Tidsram: Measured at 6 weeks, 12 weeks and 12 months postoperatively
|
Range of movement of thumb measured by physiotherapist.
Extension, flexion, volar abduction, radial abduction.
In degrees.
|
Measured at 6 weeks, 12 weeks and 12 months postoperatively
|
|
Metacarpophalangeal (MCP)-joint hyperextension
Tidsram: Measured at 6 weeks, 12 weeks and 12 months postoperatively
|
Radiographic MCP-joint hyperextension (Z-deformity)
|
Measured at 6 weeks, 12 weeks and 12 months postoperatively
|
|
Complications
Tidsram: Measured at 6 weeks, 12 weeks and 12 months postoperatively
|
Complications, such as trigger thumb, de Quervain's, reoperation, and infection, reported within 12 months of surgery.
|
Measured at 6 weeks, 12 weeks and 12 months postoperatively
|
|
Use of analgesics
Tidsram: Measured at 12 months postoperatively
|
Total usage of analgesic during the post operative period.
|
Measured at 12 months postoperatively
|
|
Duration of sick leave
Tidsram: Measured at 12 months postoperatively
|
Total duration of sick leave.
|
Measured at 12 months postoperatively
|
|
Patient-reported outcomes EQ-5D
Tidsram: Measured at 6 weeks, 12 weeks and 12 months postoperatively
|
Patient-reported outcome of the hand surgery using validated questionnaire EQ-5D
|
Measured at 6 weeks, 12 weeks and 12 months postoperatively
|
|
Patient-reported outcomes PRWHE
Tidsram: Measured at 6 weeks, 12 weeks and 12 months postoperatively
|
Patient-reported outcome of the hand surgery using validated questionnaire PRWHE
|
Measured at 6 weeks, 12 weeks and 12 months postoperatively
|
Samarbetspartners och utredare
Sponsor
Utredare
- Studierektor: Nils Hailer, MD, PhD. Professor, Department of orthopaedics and hand surgery, Akademiska hospital, Uppsala, Sweden
- Huvudutredare: Sara Edsfeldt, MD, PhD, senior attending, Department of orthopaedics and hand surgery, Akademiska hospital, Uppsala, Sweden
- Studiestol: Sara Edsfeldt, MD, PhD, senior attending, Department of orthopaedics and hand surgery, Akademiska hospital, Uppsala, Sweden
Publikationer och användbara länkar
Allmänna publikationer
- Kim JK, Park MG, Shin SJ. What is the minimum clinically important difference in grip strength? Clin Orthop Relat Res. 2014 Aug;472(8):2536-41. doi: 10.1007/s11999-014-3666-y. Epub 2014 May 10.
- Lang CE, Edwards DF, Birkenmeier RL, Dromerick AW. Estimating minimal clinically important differences of upper-extremity measures early after stroke. Arch Phys Med Rehabil. 2008 Sep;89(9):1693-700. doi: 10.1016/j.apmr.2008.02.022.
- Kriegs-Au G, Petje G, Fojtl E, Ganger R, Zachs I. Ligament reconstruction with or without tendon interposition to treat primary thumb carpometacarpal osteoarthritis. A prospective randomized study. J Bone Joint Surg Am. 2004 Feb;86(2):209-18. doi: 10.2106/00004623-200402000-00001.
- Bohannon RW. Minimal clinically important difference for grip strength: a systematic review. J Phys Ther Sci. 2019 Jan;31(1):75-78. doi: 10.1589/jpts.31.75. Epub 2019 Jan 10.
- Werle S, Goldhahn J, Drerup S, Simmen BR, Sprott H, Herren DB. Age- and gender-specific normative data of grip and pinch strength in a healthy adult Swiss population. J Hand Surg Eur Vol. 2009 Feb;34(1):76-84. doi: 10.1177/1753193408096763. Epub 2009 Jan 7.
- Herren DB, Marks M, Neumeister S, Schindele S. Low complication rate and high implant survival at 2 years after Touch(R) trapeziometacarpal joint arthroplasty. J Hand Surg Eur Vol. 2023 Oct;48(9):877-883. doi: 10.1177/17531934231179581. Epub 2023 Jun 13.
- Kierkegaard M, Petitclerc E, Hebert LJ, Mathieu J, Gagnon C. Responsiveness of performance-based outcome measures for mobility, balance, muscle strength and manual dexterity in adults with myotonic dystrophy type 1. J Rehabil Med. 2018 Feb 28;50(3):269-277. doi: 10.2340/16501977-2304.
- Draak TH, Pruppers MH, van Nes SI, Vanhoutte EK, Bakkers M, Gorson KC, Van der Pol WL, Lewis RA, Notermans NC, Nobile-Orazio E, Leger JM, Van den Bergh PY, Lauria G, Bril V, Katzberg H, Lunn MP, Pouget J, van der Kooi AJ, van den Berg LH, van Doorn PA, Cornblath DR, Hahn AF, Faber CG, Merkies IS; PeriNomS study group. Grip strength comparison in immune-mediated neuropathies: Vigorimeter vs. Jamar. J Peripher Nerv Syst. 2015 Sep;20(3):269-76. doi: 10.1111/jns.12126.
- Guzzini M, Arioli L, Annibaldi A, Pecchia S, Latini F, Ferretti A. Interposition Arthroplasty versus Dual Cup Mobility Prosthesis in Treatment of Trapeziometacarpal Joint Osteoarthritis: A Prospective Randomized Study. Hand (N Y). 2024 Nov;19(8):1260-1268. doi: 10.1177/15589447231185584. Epub 2023 Jul 23.
- Newton A, Talwalkar S. Arthroplasty in thumb trapeziometacarpal (CMC joint) osteoarthritis: An alternative to excision arthroplasty. J Orthop. 2022 Nov 26;35:134-139. doi: 10.1016/j.jor.2022.11.011. eCollection 2023 Jan.
Studieavstämningsdatum
Studera stora datum
Studiestart (Beräknad)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
- Kostnads-nyttoanalys
- Prospektiva studier
- Greppstyrka
- protes
- Första karpometakarpalleden
- Jämförande studie
- Randomized Controlled Trial (RCT)
- Rhizarthrosis
- Trapeziektomi
- Återgå till arbete
- handkirurgi
- Tummen Artros
- Prospektiv studie
- EQ-5D
- Total ledplastik
- Livskvalitet (QoL)
- Patient Reported Outcome Measures (PROMs)
- Hälsoekonomi
- QuickDASH
- Hälsorelaterad livskvalitet (HRQoL)
- Nyp styrka
- Kostnadseffektivitetsanalys
- Kirurgisk rekonstruktion
- Trapeziometakarpalleden
- Thumb base arthroplasty
- CMC joint
- Dual Mobility Prosthesis
- Total Joint Replacement
- Ligament Reconstruction
- Michigan Hand Outcomes Questionnaire (MHQ
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- Dnr2026-00547-01
- 2026-00547-01 (Annan identifierare: Swedish Ethical Review Authority)
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
Tidsram för IPD-delning
Kriterier för IPD Sharing Access
IPD-delning som stöder informationstyp
- STUDY_PROTOCOL
- SAV
- ICF
- CSR
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .